References
- Anandan C, Elton R, Hitchings A, Brewster DH (2008). Nasopharyngeal cancer incidence and survival in Scotland, 1975-2001. Clin Otolaryngol, 33, 12-27. https://doi.org/10.1111/j.1749-4486.2007.01590.x
- Banister J, Hill K (2004). Mortality in China 1964-2000. Popul Stud, 58, 55-75. https://doi.org/10.1080/0032472032000183753
- Baujat B, Audry H, Bourhis J, et al (2006). MAC-NPC Collaborative Group. MAC-NPC Collaborative Group. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev, 6, CD004329.
- Buell P (1974). The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res, 34, 1189-91.
- Chan AT, Teo PM, Leung TW, Johnson PJ (1998). The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer, 82, 1003-12. https://doi.org/10.1002/(SICI)1097-0142(19980315)82:6<1003::AID-CNCR1>3.0.CO;2-F
- Chang ET, Adami HO (2006). The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 1765-77. https://doi.org/10.1158/1055-9965.EPI-06-0353
- Cheng Z (2008). Report on the third national retrospective deathcauses sampling survey in China. Peking Union Medical College Press, Beijing, 1-214.
- Chien YC, Chen JY, Liu MY, Yang HI, et al (2001). Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med, 345, 1877-82. https://doi.org/10.1056/NEJMoa011610
- Dai XD, Li LD, Lu FZ (1999). Trend of China nasopharyngeal carcinoma in 20 years and its prediction in the near future. J Prac Oncol, 13, 1-5.
- Deng H, Zeng Y, Lei Y, et al (1995). Serological survey of nasopharyngeal carcinoma in 21 cities of south China. Chin Med J, 108, 300-3.
- Faggiano F, Partanen T, Kogevinas M, Boffetta P,et al (1997). Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ, 138, 65-176.
- Guo X, Johnson RC, Deng H, Liao J, Guan L, et al (2009). Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer, 124, 2942-7.
- Huang TB, Wang HM, Li JL, et al (1997). Identification of high risk populations for nasopharyngeal carcinoma. Chin J Cancer, 16, 81-4.
- Jia WH, Huang QH, Liao J, et al (2006). Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer, 6, 178. https://doi.org/10.1186/1471-2407-6-178
- Jin F, Devesa SS, Chow WH, Zheng W, Ji BT,et al (1999). Gao YT. Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer, 83,435-40. https://doi.org/10.1002/(SICI)1097-0215(19991112)83:4<435::AID-IJC1>3.0.CO;2-J
- Kong L, Zhang YW (2008). Historical evolution in the diagnosis and treatment of nasopharyngeal carcinoma. China Oncol, 18, 641-7.
- La Vecchia C, Negri E, Levi F, Decarli A, Boyle P (1998). Cancer mortality in Europe: effects of age, cohort of birth and period of death. Eur J Cancer, 34, 118-41. https://doi.org/10.1016/S0959-8049(97)00335-3
- Lee AW, Foo W, Mang O, et al (2003). Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality. Int J Cancer, 103, 680-5. https://doi.org/10.1002/ijc.10894
- Lee JT, Ko CY (2005). Has survival improved for nasopharyngeal carcinoma in the United States? Otolaryngol Head Neck Surg, 132, 303-8. https://doi.org/10.1016/j.otohns.2004.09.018
- Li LD, Lu FZ, Zhang SW, et al (1996). Analysis of cancer mortality and distribution in China from year 1990 through 1992. An epidemiologic study. Chin J Oncol, 18, 403-7.
- Lu TX (2009). Diagnosis and treatment of nasopharyngeal carcinoma: 30 years of change and progress in China. Chinese J Clinicians;3 (Electronic Version).
- National Office for Cancer prevention and Control (NOCPC) (1979). Investigation of Cancer Mortality in China. People's Health Publishing House, 1979.
- National Center of Health Information and Statistics (NCHIS) (1999). Annual report for national health information and statistics. Beijing, P.R. China, 1999.
- National Office for Cancer prevention and Control (NOCPC) (2008). Survey of Cancer Mortality in China (1990 - 1992). People's Health Publishing House. P.1-629.
- Ou SH, Zell JA, Ziogas A (2007). Anton-Culver H. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol, 18, 29-35. https://doi.org/10.1093/annonc/mdl447
- Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Parkin DM,Whelan SL,Ferlay J, et al (1997). Cancer incidence in five continents.Vol 7. Lyon, France: International Agency for Research on Cancer, 334-7.
- Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995). Clonal proliferations of cells infected with Epstein- Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med, 333, 693-8. https://doi.org/10.1056/NEJM199509143331103
- Population Census Office (1982). National Bureau of Statistics. 1982 Population Census of China. China Statistics Press, Beijing.
- Rischin D, Corry J, Smith J, et al (2002). Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation. J Clin Oncol, 20, 1845-52. https://doi.org/10.1200/JCO.2002.07.011
- Spano JP, Busson P, Atlan D, et al (2003). Nasopharyngeal carcinomas: an update. Eur J Cancer, 39, 2121-35. https://doi.org/10.1016/S0959-8049(03)00367-8
- The Editorial Committee (1979). Atlas of cancer mortality in the people's Republic of China. Shanghai, China Map Press. P. 1-99.
- Waterhouse J, Muir C, Correa P, Powell J (1976). Cancer incidence in five continents. Lyon, IARC Sci Publ: 456.
- Wei KR, Yu YL, Yang YY, et al (2010). Epidemiological trends of nasopharyngeal carcinoma in China. Asian Pac J Cancer Prev, 11, 29-32.
- Wong CH, Kelly LE, Tripcony LB (2007). Nasopharygeal carcinoma in Queensland, Australia: a review of 10 years experience. Australia Radiol, 51, 276-82. https://doi.org/10.1111/j.1440-1673.2007.01730.x
- Yang L, Parkin DM, Li L, Chen Y (2003). Sources of information on the burden of cancer in China. Asian Pac J Cancer Prev, 4, 23-30.
- Yang L, Parkin DM, Li LD, Chen YD, Bray F (2004). Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer, 90, 2157-66.
- Yang L, Parkin DM, Li L, Chen Y (2004). A comparison of the sources of cancer mortality in China. Cancer Causes Control, 15, 681-7. https://doi.org/10.1023/B:CACO.0000036181.37225.91
- Yu MC, Ho JH, Lai SH, Henderson BE (1986). Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res, 46, 956-61.
- Yu MC, Yuan JM (2002). Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol, 12, 421-9. https://doi.org/10.1016/S1044579X02000858
- Yu WM, Hussain SS (2009). Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review. J Laryngol Otol, 123, 1067-74. https://doi.org/10.1017/S0022215109005623
- Zhang CQ, Zhong YS, Sun Y, et al (2004). The application of serum EBNA1- IgA and EA- IgG markers in early diagnosis of nasopharyngeal carcinoma. Chin J Oncol, 26, 482-4.
- Zhang SW, Chen WQ, Wei WQ, Li GL, Li N (2010). Ovary cancer mortality in China 2004 - 2005: results from the Third National Retrospective Sampling Survey of Death Causes. Chin J Prev Med, 44, 418-22
- Zhou YS, Zhang SW, Li LD (1997). Analysis for death for all and malignant tumors for Chinese population. Bull Chin Can, 6, 9-11.
Cited by
- Expression of the Pokemon Proto-oncogene in Nasopharyngeal Carcinoma Cell Lines and Tissues vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6315
- Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate vol.43, pp.5, 2013, https://doi.org/10.3892/ijo.2013.2080
- Prognostic factors for survival of patients with nasopharyngeal carcinoma following conventional fractionation radiotherapy vol.6, pp.1, 2013, https://doi.org/10.3892/etm.2013.1100
- Expression of the Annexin A1 gene is associated with suppression of growth, invasion and metastasis of nasopharyngeal carcinoma vol.10, pp.6, 2014, https://doi.org/10.3892/mmr.2014.2656
- ABO Blood Group, Epstein-Barr virus Infection and Prognosis of Patients with Non-metastatic Nasopharyngeal Carcinoma vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7459
- Diagnostic Significance of Combined Detection of Epstein-Barr Virus Antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for Nasopharyngeal Carcinoma vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2001
- Reirradiation with Robotic Stereotactic Body Radiotherapy for Recurrent Nasopharyngeal Carcinoma vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3561
- Retrograde Analysis of Clinical Characteristics of Bone Metastasis in 1,031 Cases of Preliminarily Diagnosed Nasopharyngeal Carcinoma vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3785
- Effect of the vascular endothelial growth factor expression level on angiopoietin-2-mediated nasopharyngeal carcinoma growth vol.6, pp.1, 2014, https://doi.org/10.1186/2045-824X-6-4
- Declining Incidence of Nasopharyngeal Carcinoma in Brunei Darussalam: a Three Decade Study (1986-2014) vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7097
- Nasopharyngeal Carcinoma Incidence in North Tunisia: Negative Trends in Adults but not Adolescents, 1994-2006 vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2653
- Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients vol.20, pp.12, 2016, https://doi.org/10.1111/jcmm.12906
- An open-label, single-arm phase II clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma vol.27, pp.7, 2016, https://doi.org/10.1097/CAD.0000000000000370
- Low expression of Aldo–keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma vol.6, pp.1, 2016, https://doi.org/10.1186/s13578-016-0082-x
- Molecular pathological study of the human nasopharyngeal carcinoma CNE3 cell line vol.6, pp.4, 2013, https://doi.org/10.3892/ol.2013.1513